SARS-CoV-2 Antibody Levels After COVID-19 Restrictions Eased in China
Author Information
Author(s): Ling Feng, Xu Zenghao, Sun Jimin, Wang Xiaoxiao, Feng Yan, Liu Ying, Chen Yijuan, Wang Jinna, Chen Zhiping, Chen Kun
Primary Institution: Zhejiang Provincial Center for Disease Control and Prevention
Hypothesis
What are the seroprevalence and antibody trajectories of SARS-CoV-2 after easing COVID-19 restrictions in China?
Conclusion
The majority of the population maintained sustained protective immunity after the outbreak, following the easing of COVID-19 restrictions across the country.
Supporting Evidence
- 75.95% of participants maintained a high level of neutralizing antibodies throughout the study.
- COVID-19 vaccine coverage was 95.35%, with 76.61% fully vaccinated at baseline.
- Seroprevalence increased from 89.77% at baseline to 90.47% at the last follow-up.
Takeaway
Most people in China still have strong protection against COVID-19 even after restrictions were lifted, especially if they are younger, women, fully vaccinated, or have had the virus before.
Methodology
The study used a multistage, population-stratified, cluster random sampling method to conduct repeated seroepidemiologic studies and analyzed antibody trajectories using latent class growth mixed models.
Potential Biases
The study was conducted in a region with high economic status and healthcare access, which may not represent lower socioeconomic areas.
Limitations
The study measured neutralizing antibodies against the wild strain of SARS-CoV-2, which may not fully capture the immune response to Omicron variants.
Participant Demographics
Median age was 53.61 years, with 54.35% women and over 99% Han ethnicity.
Statistical Information
P-Value
p<0.001
Confidence Interval
95% CI: 88.98–90.51%
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website